FDA clears way for ClearRead CT Software The first FDA cleared device demonstrating superior nodule detection performance and faster reading using a concurrent read DAYTON, Ohio – September 19, 2016 – Riverain Technologies is committed to providing cutting edge software to aid the clinician in the efficient, effective early detection of lung disease. Today, Riverain Technologies announces ClearRead CT, a … Read More
Mayo Clinic – Jacksonville Adopts ClearRead Bone Suppression and Confirm Technology DAYTON, Ohio – July 15, 2016 – Riverain Technologies announces that Mayo Clinic – Jacksonville has adopted the ClearRead Bone Suppression and ClearRead Confirm Technology. Riverain is proud to add Mayo to a long list of prestigious institutions using the ClearRead technology. Riverain’s ClearRead Bone Suppression software is designed … Read More
Riverain Technologies Exhibits at Society of Imaging Informatics in Medicine (SIIM) Show DAYTON, Ohio – June 29, 2016 – Riverain Technologies exhibits ClearRead software at the Society of Imaging Informatics in Medicine (SIIM) show in Portland, Oregon. Riverain representatives provided attendees with detailed product demonstrations on the ClearRead technology and how the software seamlessly integrates into a facilities existing PACS … Read More
Riverain Gives Talk on the Future of Nodule Detection and Characterization in a CT Series at STR DAYTON, Ohio – March 13, 2016 – Riverain Technologies’ showcased ClearRead software at the Society of Thoracic Radiology (STR) conference as a Gold level sponsor. Riverain, CEO, Steve Worrell, presented Riverain’s ClearRead CT software as part of the invited speaking session. In a … Read More
Riverain Technologies’ ClearRead CT Software Receives CE Mark Approval DAYTON, Ohio – Nov. 18, 2015–ClearRead CT by Riverain Technologies receives CE mark approval. ClearRead CT incorporates Riverain’s patent pending ClearRead CT Vessel Suppression used to improve nodule conspicuity and reduce reading time. Additionally, ClearRead CT identifies and characterizes nodules and is proven to enhance radiologists’ CT nodule detection accuracy in … Read More
Riverain and Siemens Lands the Dayton VA DAYTON, Ohio – October 5, 2015 – Riverain continues its momentum across the VAs by installing an enterprise license of their patented ClearRead Bone Suppression solution at the Dayton VA.
Veteran Administration Extends Riverain Contract DAYTON, Ohio – August 31, 2015 – The VA extends the Riverain contract for an additional four year period for the ClearRead X-ray Suite, including; ClearRead Bone Suppression, ClearRead +Detect, ClearRead +Confirm and ClearRead +Compare.
Duke University Hospital Adopts Riverain Technologies’ ClearRead Applications DAYTON, Ohio – November 11, 2014 – Duke University Hospital has adopted Riverain’s ClearRead Bone Suppression, ClearRead +Detect, and ClearRead +Confirm software products as a way to extend the diagnostic potential of the world’s most commonly performed imaging procedure, the chest x-ray. ClearRead technology helps radiologists detect lung nodules and other serious … Read More
Bone Suppression Optimises Chest X-ray’s IPA Diagnosis (As posted on HealthManagment.org) Invasive pulmonary aspergillosis (IPA) is a major cause of morbidity and mortality, particularly in patients with haematological malignancies. A delay in treatment is associated with substantially increased hospital mortality. However, treatment is expensive, and can have serious side effects. From a clinical point of view, there is therefore a … Read More
Leading Medical Centers adopting ClearRead software to improve diagnostic power of X-ray machines Riverain Technologies revenues up 34 percent DAYTON, Ohio – Aug. 5, 2014 – Doctors are gleaning important information from the most common imaging exam, the chest X-ray, by using sophisticated software that improves X-ray images captured by the equipment they already have or are in the process … Read More